1 series
Export
<<<Page of 1 >>>Page size
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterExpression profiling by high throughput sequencing Remove filterDCC Remove filterJan 27, 2024
GSE254054
Clinical and Biomarker Results from A Phase II Trial of Combined Cabozantinib and Durvalumab in Patients with Chemotherapy-refractory Colorectal Cancer (CRC): CAMILLA CRC Cohort
  • Expression profiling by high throughput sequencing
  • Other
120 Ayah N. Al-Bzour Jan 27, 2024